181 related articles for article (PubMed ID: 27576676)
1. Anemia and low-grade inflammation in pediatric kidney transplant recipients.
Miettinen J; Tainio J; Jahnukainen T; Pakarinen M; Lauronen J; Jalanko H
Pediatr Nephrol; 2017 Feb; 32(2):347-358. PubMed ID: 27576676
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
3. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
[TBL] [Abstract][Full Text] [Related]
4. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
[TBL] [Abstract][Full Text] [Related]
5. Anemia after kidney transplantation: Does its basis differ from anemia in chronic kidney disease?
Oruç Ç; Canpolat N; Pehlivan E; Balcı Ekmekçi Ö; Ağbaş A; Çalışkan S; Sever FL
Pediatr Transplant; 2020 Dec; 24(8):e13818. PubMed ID: 32797673
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Nov; 38(9):2895-8. PubMed ID: 17112858
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort.
Atkinson MA; Kim JY; Roy CN; Warady BA; White CT; Furth SL
Pediatr Nephrol; 2015 Apr; 30(4):635-43. PubMed ID: 25380788
[TBL] [Abstract][Full Text] [Related]
8. Hemojuvelin and iron metabolism in kidney and heart allograft recipients.
Przybylowski P; Koc-Zorawska E; Glowinska I; Levin-Iaina N; Macdougall IC; Malyszko JS; Mysliwiec M; Malyszko J
Transplant Proc; 2013; 45(1):391-3. PubMed ID: 23375327
[TBL] [Abstract][Full Text] [Related]
9. The role of midkine in the inflammatory process and its correlation with other inflammatory markers in renal transplant recipients.
Uzun S; Kaya B; Celik K; Behlul A; Ozkan O; Kuvvet M; Doventas YE; Gursu M; Karadag S; Sumnu A; Cebeci E; Kocak B; Turkmen A; Ozturk S
Int J Artif Organs; 2016 Aug; 39(6):277-81. PubMed ID: 27470002
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-associated graft loss in renal transplant recipients.
Dahle DO; Mjøen G; Oqvist B; Scharnagl H; Weihrauch G; Grammer T; März W; Abedini S; Norby GE; Holme I; Fellström B; Jardine A; Holdaas H
Nephrol Dial Transplant; 2011 Nov; 26(11):3756-61. PubMed ID: 21511816
[TBL] [Abstract][Full Text] [Related]
11. Impact of serum hepcidin and inflammatory markers on resistance to erythropoiesis-stimulating therapy in haemodialysis patients.
El Sewefy DA; Farweez BA; Behairy MA; Yassin NR
Int Urol Nephrol; 2019 Feb; 51(2):325-334. PubMed ID: 30600440
[TBL] [Abstract][Full Text] [Related]
12. Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation.
Xue D; He X; Zhou C
Transplant Proc; 2014; 46(1):156-9. PubMed ID: 24507043
[TBL] [Abstract][Full Text] [Related]
13. Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.
Hong JH; Choi YK; Min BK; Park KS; Seong K; Lee IK; Kim JG
Diabetes Res Clin Pract; 2015 Jul; 109(1):64-70. PubMed ID: 25998917
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients.
Borawski J; Pawlak K; Myśliwiec M
Nephron; 2002 Aug; 91(4):671-81. PubMed ID: 12138272
[TBL] [Abstract][Full Text] [Related]
15. Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD.
Axelsson J; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P; Bárány P
Am J Kidney Dis; 2005 Oct; 46(4):628-34. PubMed ID: 16183417
[TBL] [Abstract][Full Text] [Related]
16. Low 1,25-dihydroxyvitamin D level is associated with erythropoietin deficiency and endogenous erythropoietin resistance in patients with chronic kidney disease.
Kim IY; Kim JH; Kim MJ; Lee DW; Hwang CG; Han M; Rhee H; Song SH; Seong EY; Lee SB
Int Urol Nephrol; 2018 Dec; 50(12):2255-2260. PubMed ID: 30136086
[TBL] [Abstract][Full Text] [Related]
17. Anemia in heart and kidney allograft recipients: is there a role for hepcidin?
Przybylowski P; Malyszko J; Malyszko JS; Koc-Zorawska E; Sadowski J; Mysliwiec M
Transplant Proc; 2010 Dec; 42(10):4255-8. PubMed ID: 21168677
[TBL] [Abstract][Full Text] [Related]
18. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
[TBL] [Abstract][Full Text] [Related]
19. GDF15 is related to anemia and hepcidin in kidney allograft recipients.
Malyszko J; Koc-Zorawska E; Malyszko JS; Glowinska I; Mysliwiec M; Macdougall IC
Nephron Clin Pract; 2013; 123(1-2):112-7. PubMed ID: 23797049
[TBL] [Abstract][Full Text] [Related]
20. Serum Soluble-Fas, Inflammation, and Anemia in Acute Kidney Injury.
Góes MA; Iizuka IJ; Quinto BM; Dalboni MA; Monte JC; Santos BC; Dos Santos OFP; Pereira VG; Durão MS; Batista MC; Cendoroglo M
Artif Organs; 2018 Sep; 42(9):E283-E289. PubMed ID: 23566289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
